Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neonatal intravenous-to-oral antibiotic switch therapy trial
NL-OMON47298Phase 4Active, not recruiting
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin + clavulanate in bacterial disease (2 arms), sponsored by Franciscus Gasthuis & Vlietland. Started Feb 2018; status: active, not recruiting.
02
Drugs
amoxicillin + clavulanate
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON47298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47298.